Bednarz-Misa, I.; Fleszar, M.G.; Zawadzki, M.; Kapturkiewicz, B.; Kubiak, A.; Neubauer, K.; Witkiewicz, W.; Krzystek-Korpacka, M.
L-Arginine/NO Pathway Metabolites in Colorectal Cancer: Relevance as Disease Biomarkers and Predictors of Adverse Clinical Outcomes Following Surgery. J. Clin. Med. 2020, 9, 1782.
https://doi.org/10.3390/jcm9061782
AMA Style
Bednarz-Misa I, Fleszar MG, Zawadzki M, Kapturkiewicz B, Kubiak A, Neubauer K, Witkiewicz W, Krzystek-Korpacka M.
L-Arginine/NO Pathway Metabolites in Colorectal Cancer: Relevance as Disease Biomarkers and Predictors of Adverse Clinical Outcomes Following Surgery. Journal of Clinical Medicine. 2020; 9(6):1782.
https://doi.org/10.3390/jcm9061782
Chicago/Turabian Style
Bednarz-Misa, Iwona, Mariusz G. Fleszar, Marek Zawadzki, Bartosz Kapturkiewicz, Agnieszka Kubiak, Katarzyna Neubauer, Wojciech Witkiewicz, and Małgorzata Krzystek-Korpacka.
2020. "L-Arginine/NO Pathway Metabolites in Colorectal Cancer: Relevance as Disease Biomarkers and Predictors of Adverse Clinical Outcomes Following Surgery" Journal of Clinical Medicine 9, no. 6: 1782.
https://doi.org/10.3390/jcm9061782
APA Style
Bednarz-Misa, I., Fleszar, M. G., Zawadzki, M., Kapturkiewicz, B., Kubiak, A., Neubauer, K., Witkiewicz, W., & Krzystek-Korpacka, M.
(2020). L-Arginine/NO Pathway Metabolites in Colorectal Cancer: Relevance as Disease Biomarkers and Predictors of Adverse Clinical Outcomes Following Surgery. Journal of Clinical Medicine, 9(6), 1782.
https://doi.org/10.3390/jcm9061782